| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
NeuPath Health Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.17 |
| 52 Week High | CA$0.25 |
| 52 Week Low | CA$0.13 |
| Beta | 0.76 |
| 1 Month Change | 6.25% |
| 3 Month Change | -5.56% |
| 1 Year Change | 0% |
| 3 Year Change | -75.36% |
| 5 Year Change | n/a |
| Change since IPO | -81.11% |
Recent News & Updates
The Market Doesn't Like What It Sees From NeuPath Health Inc.'s (CVE:NPTH) Revenues Yet
Apr 23
Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?
Mar 01Revenues Not Telling The Story For NeuPath Health Inc. (CVE:NPTH) After Shares Rise 27%
Dec 20Recent updates
The Market Doesn't Like What It Sees From NeuPath Health Inc.'s (CVE:NPTH) Revenues Yet
Apr 23Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?
Mar 01Revenues Not Telling The Story For NeuPath Health Inc. (CVE:NPTH) After Shares Rise 27%
Dec 20Little Excitement Around NeuPath Health Inc.'s (CVE:NPTH) Revenues
Aug 19Shareholder Returns
| NPTH | CA Healthcare | CA Market | |
|---|---|---|---|
| 7D | 0% | 0.8% | 1.1% |
| 1Y | 0% | 5.9% | 10.8% |
Return vs Industry: NPTH underperformed the Canadian Healthcare industry which returned 5.9% over the past year.
Return vs Market: NPTH underperformed the Canadian Market which returned 10.8% over the past year.
Price Volatility
| NPTH volatility | |
|---|---|
| NPTH Average Weekly Movement | 9.3% |
| Healthcare Industry Average Movement | 5.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CA Market | 17.8% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: NPTH has not had significant price volatility in the past 3 months.
Volatility Over Time: NPTH's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 156 | Joe Walewicz | www.neupath.com |
NeuPath Health Inc. provides chronic pain management services in Canada. The company offers chronic pain assessment and multi-modal treatment plan that helps patient to manage pain and optimize quality of life. It also provides workplace health services and independent medical assessments to employers and disability insurers through a national network of health care providers comprising cardiologists, dentists, dermatologists, endocrinologists, psychiatrists, gastroenterologists, general practitioners, internal medicine specialists, neurologists, neuropsychiatrists, neuropsychologists, occupational therapists, ophthalmologists, orthopedic surgeons, physiatrists, physiotherapists, psychologists, respirologists, and rheumatologists.
NeuPath Health Inc. Fundamentals Summary
| NPTH fundamental statistics | |
|---|---|
| Market cap | CA$9.57m |
| Earnings (TTM) | -CA$293.00k |
| Revenue (TTM) | CA$67.53m |
0.1x
P/S Ratio-32.7x
P/E RatioIs NPTH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NPTH income statement (TTM) | |
|---|---|
| Revenue | CA$67.53m |
| Cost of Revenue | CA$54.89m |
| Gross Profit | CA$12.63m |
| Other Expenses | CA$12.93m |
| Earnings | -CA$293.00k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0052 |
| Gross Margin | 18.71% |
| Net Profit Margin | -0.43% |
| Debt/Equity Ratio | 26.3% |
How did NPTH perform over the long term?
See historical performance and comparison